Joseph A. Akers

This profile gathers the share dealings of Joseph A. Akers in Titan Pharmaceuticals Inc. We count 3 filings; the first trade dates from 18 July 2016 and the latest from 21 September 2018.

Purchases make up the whole of the open-market record (3 purchases, €99k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2018, the count stands at 1 purchase and no sales.

A typical purchase (the median) is worth €36k. 3 out of 3 purchases came within 30 days of a purchase by at least one other insider of the same company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

The latest filing, published on 25 September 2018, reports an open-market purchase of €42k in Titan Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.